Scientists say they've developed drug that can prevent menopause ever happening

A group of scientists are developing an "anti-menopause shot" that could stop women from experiencing menopause all together in a breaksthrough new trial.

Campaigners have been asking for more treatment options for women going through the difficult symptoms of menopause.

Hot flashes, brain fog, changes in mood and extreme tiredness are just some of them.

Scientists in New York from biotech company Oviva Theraputics, said the injection, which could be given once every few months, acts like a hormone called anti-Mullerian hormone (AMH), which is involved in ovulation and starts to drop when a woman turns 25.

During menopausal age, which is usually between 45 and 55, they see a big drop in reproductive hormones needed for pregnancy.

READ MORE: Doctor reveals the red flag signs of 7 silent killers you might easily ignore

But the researchers suggest that injecting women with AMH every few months could artificially raise levels of the hormone AMH.

This, they said, could delay the shift, maybe forever.

However, risks didn't disclose any risks from the drug, but regular HRT has been shown to increase the risk of breast and endometrial cancer.

Dr Daisy Robinton, a molecular biologist at Oviva Therapeutics who's working on the development, told DailyMail.com: "This drug couldn't just delay the menopause, it could actually prevent it."

DON'T MISS: Kate hires top team to 'work around the clock' on new plan for royal return [LATEST]More than 450,000 cancer patients miss treatment target since 2019  [COMMENT]Three essential vegetables everyone should be eating, according to a doctor [ANALYSIS]

Every cycle, a woman loses around 1,000 follicles - either through ovulation, where eggs are released, or through the natural death of cells.

But scientists have discovered that when a woman has higher levels of AMH this loss can be slowed down.

The drug is currently being tested in mice to show if it is safe to use, with results expected in the next few months.

If successful, it could move to trials in humans within the next few years.

Follow our social media accounts here on facebook.com/ExpressUSNews and @expressusnews